OBJECTIVES: Lipids are linked to many pathological processes including hepatic steatosis and liver malignancy. This study aimed to explore lipid metabolism in hepatitis C virus (HCV) and HCV-related hepatocellular carcinoma (HCC). METHODS: Serum lipids were measured in normal, HCV and HCV-HCC patients. Whole-genome microarray was performed to identify potential signature genes involved in lipid metabolism characterizing normal vs. HCV vs. HCV-HCC conditions. RESULTS: Serum cholesterol was significantly reduced in HCV and HCV-HCC patients compared with normal controls, whereas there was no difference in glucose and triglycerides. Microarray analysis identified 224 probe sets with known functional roles in lipid metabolism (anova, 1.5-fold, P ≤ 0.001). Gene-mediated fatty acid (FA) de novo synthesis and uptake were upregulated in HCV and this upregulation was further enhanced in HCC. Genes involved in FA oxidation were downregulated in both the HCV and HCC groups. The abnormality of cholesterol metabolism in HCV was associated with downregulation of genes involved in cholesterol biosynthesis, absorption and transportation and bile acid synthesis; this abnormality was further intensified in HCC. CONCLUSIONS: Our data support the notion that HCV-related lipid metabolic abnormalities may contribute to hepatic steatosis and the development of cancer. Identification of these aberrations would stratify patients and improve treatment algorithms.
OBJECTIVES:Lipids are linked to many pathological processes including hepatic steatosis and liver malignancy. This study aimed to explore lipid metabolism in hepatitis C virus (HCV) and HCV-related hepatocellular carcinoma (HCC). METHODS: Serum lipids were measured in normal, HCV and HCV-HCC patients. Whole-genome microarray was performed to identify potential signature genes involved in lipid metabolism characterizing normal vs. HCV vs. HCV-HCC conditions. RESULTS: Serum cholesterol was significantly reduced in HCV and HCV-HCC patients compared with normal controls, whereas there was no difference in glucose and triglycerides. Microarray analysis identified 224 probe sets with known functional roles in lipid metabolism (anova, 1.5-fold, P ≤ 0.001). Gene-mediated fatty acid (FA) de novo synthesis and uptake were upregulated in HCV and this upregulation was further enhanced in HCC. Genes involved in FA oxidation were downregulated in both the HCV and HCC groups. The abnormality of cholesterol metabolism in HCV was associated with downregulation of genes involved in cholesterol biosynthesis, absorption and transportation and bile acid synthesis; this abnormality was further intensified in HCC. CONCLUSIONS: Our data support the notion that HCV-related lipidmetabolic abnormalities may contribute to hepatic steatosis and the development of cancer. Identification of these aberrations would stratify patients and improve treatment algorithms.
Authors: Jian-Min Wu; Hongmiao Sheng; Romil Saxena; Nicholas James Skill; Poornima Bhat-Nakshatri; Menggang Yu; Harikrishna Nakshatri; Mary A Maluccio Journal: Cancer Lett Date: 2009-03-20 Impact factor: 8.679
Authors: Frank Staib; Markus Krupp; Thorsten Maass; Timo Itzel; Arndt Weinmann; Ju-Seog Lee; Bertil Schmidt; Martina Müller; Snorri S Thorgeirsson; Peter R Galle; Andreas Teufel Journal: Liver Int Date: 2013-09-09 Impact factor: 5.828
Authors: Mohamed I F Shariff; Joshua M Tognarelli; Matthew R Lewis; Elizabeth J Want; Fatma El Zahra Mohamed; Nimzing G Ladep; Mary M E Crossey; Shahid A Khan; Rajiv Jalan; Elaine Holmes; Simon D Taylor-Robinson Journal: J Clin Exp Hepatol Date: 2015-07-18
Authors: Ragunath Singaravelu; Shifawn O'Hara; Daniel M Jones; Ran Chen; Nathan G Taylor; Prashanth Srinivasan; Curtis Quan; Dominic G Roy; Rineke H Steenbergen; Anil Kumar; Rodney K Lyn; Dennis Özcelik; Yanouchka Rouleau; My-Anh Nguyen; Katey J Rayner; Tom C Hobman; David Lorne Tyrrell; Rodney S Russell; John Paul Pezacki Journal: Nat Chem Biol Date: 2015-10-19 Impact factor: 15.040
Authors: Neil H Bhayani; Omar Hyder; Wayne Frederick; Richard D Schulick; Christopher L Wolgang; Kenzo Hirose; Barish Edil; Joseph M Herman; Michael A Choti; Timothy M Pawlik Journal: Surgery Date: 2012-08 Impact factor: 3.982
Authors: Angela L Rasmussen; Deborah L Diamond; Jason E McDermott; Xiaoli Gao; Thomas O Metz; Melissa M Matzke; Victoria S Carter; Sarah E Belisle; Marcus J Korth; Katrina M Waters; Richard D Smith; Michael G Katze Journal: J Virol Date: 2011-09-14 Impact factor: 5.103
Authors: Donna N Douglas; Christopher Hao Pu; Jamie T Lewis; Rakesh Bhat; Anwar Anwar-Mohamed; Michael Logan; Garry Lund; William R Addison; Richard Lehner; Norman M Kneteman Journal: J Biol Chem Date: 2015-12-01 Impact factor: 5.157